Search

Displaying results 1021 - 1030 of 10000 in total
  1. Drug

    Sodium phosphate, monobasic

    go.drugbank.com/drugs/DB09449
    ApprovedInvestigational

    Sodium phosphate is a saline laxative that is thought to work by increasing fluid in the small intestine. It usually results in a bowel movement after 30 minutes to 6 hours.

    Mixtures: TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood, ENEMA 161 MG/ML+59 MG/ML REKTAL ÇÖZELTİ, 135 MLCategories: Drugs for Treatment of Hypercalcemia
  2. Drug

    Simethicone

    go.drugbank.com/drugs/DB09512
    ApprovedInvestigational

    Simethicone is a silicon based surfactant that decreases the surface tension of gastrointestinal gas bubbles to facilitate their elimination.

    Mixtures: TRIMEBUTINA 200 MG + SIMETICONA 120 MG, TRIMEBUTINA 200 MG + SIMETICONA 120 MGCategories: Compounds used in a research, industrial, or household setting
  3. Drug

    Tiapride

    go.drugbank.com/drugs/DB13025
    Investigational

    Tiapride is a selective D2 and D3 dopamine receptor blocker in the brain.

    Products: TIAPRID-NEURAX 100 MG, TIAPRID-NEURAX 200 MG
  4. Drug

    Pseudoephedrine

    go.drugbank.com/drugs/DB00852
    Approved

    [A188823] The decongestant effect of pseudoephedrine was described in dogs in 1927.[A188823] … Pseudoephedrine is structurally related to [ephedrine] but exerts a weaker effect on the sympathetic nervous system.

    Mixtures: Sinu-C Suspension, DESENFRIOL-ON GRAGEAS REPETABSCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  5. Drug

    IMMU-114

    go.drugbank.com/drugs/DB18458
    Investigational

    IMMU-114 is antibody-drug conjugate consisting of humanized anti-HLA-DR IgG4 monoclonal antibody specific for alpha-chain linked to SN-38 via a CL2A linker.

  6. Drug

    Protamine sulfate

    go.drugbank.com/drugs/DB09141
    ApprovedInvestigational

    heparin use for over 77 years [A174778, A174781]. … As a consequence, whenever protamine sulfate use is clinically considered, careful consideration must be given as to whether the use of the agent could decrease the safety of the procedure or worsen the

    Products: PROTAMINE SULPHATE INJECTION 10 mg/ml, PROTAMINE SULPHATE INJECTION BP 50 mg/5 ml
  7. Drug

    Moxidectin

    go.drugbank.com/drugs/DB11431
    ApprovedInvestigationalVet approved

    It is a semi-synthetic methoxine derivative of nemadectin which is a 16-member pentacyclic lactone of the milbemycin class. … Moxidectin differs by the absence of a disaccharide moiety on carbon 13, a substituted olefinic side chain at carbon 25 and a unique methoxime moiety at carbon 23.

    Mixtures: Advocate Spot-on Solution for Small Dogs, Advocate Spot-on Solution for Large DogsCategories: Compounds used in a research, industrial, or household setting
  8. Drug

    Ridogrel

    go.drugbank.com/drugs/DB01207
    Experimental

    However, there currently are no clinical indications for preferential use of ridogrel over aspirin. … Ridogrel is a dual action drug useful for the prevention of systemic thrombo-embolism and as an adjunctive agent to thrombolytic therapy in acute myocardial infarction.

  9. Drug

    Biotin

    go.drugbank.com/drugs/DB00121
    ApprovedInvestigationalNutraceutical

    It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk.

    Mixtures: RE Nata OB, Cavan Heme OBProducts: Curatin 5 mg - Tabletten, Curatin 2,5 mg - Tabletten
  10. Drug

    Risedronic acid

    go.drugbank.com/drugs/DB00884
    ApprovedInvestigational

    Risedronic acid is a third generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label][A959,A203111]. … It functions by preventing resorption of bone[FDA Label][A959].

    Mixtures: RISEPLUS D3 35 MG/5600 IU EFERVESAN TABLET, 4 ADET, RISEPLUS D3 35 MG/2800 IU EFERVESAN TABLET, 12 ADETCategories: Drugs for Treatment of Bone Diseases